Browsing by Author Ordóñez-Llanos, Jordi

Showing results 1 to 12 of 12
TitleAuthor(s)???itemlist.dc.contributor.advisor??????itemlist.dc.contributor.editor??????itemlist.dc.contributor.titulacion???Issue Date???itemlist.dc.identifier.doi??????itemlist.dc.source??????itemlist.dc.description.sjr??????itemlist.dc.description.sjrq??????itemlist.dc.description.jcr??????itemlist.dc.description.jcrq???TypePreview
Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patientsWägner, Ana Marı́a ; Ordóñez-Llanos, Jordi; Hernández, Marta; Luis Sánchez-Quesada, Jose; Blanco-Vaca, Francisco, et al200110.1016/S0953-6205(01)00178-9European Journal of Internal Medicine[ISSN 0953-6205],v. 12, p. 496-502Artículo
Apolipoproteins and prediction of fatal myocardial infarction [5] (multiple letters)Wägner, Ana María ; Ordóñez-Llanos, Jordi; Walldius, Göran; Jungner, Ingmar; Aastveit, Are, et al2002Lancet[ISSN 0140-6736],v. 359, p. 1863-1864Comentario
The effect of VLDL particles on the accuracy of a direct LDL-cholesterol method in type 2 diabetic patientsWägner, Ana María ; Zapico, Edgar; Bonet, Rosa; Pérez, Antonio; Ordóñez-Llanos, Jordi200310.1016/S0009-9120(03)00006-7Clinical Biochemistry[ISSN 0009-9120],v. 36, p. 177-1831,825Q2Artículo
Effect of improving glycemic control on low-density lipoprotein particle size in type 2 diabetesWägner, Ana María ; Jorba, Oscar; Rigla, Mercedes; Bonet, Rosa; De Leiva, Alberto, et al200310.1016/S0026-0495(03)00326-3Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 52, p. 1576-15782,013Q3Artículo
Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patientsWagner, Ana Maria ; Perez, Antonio; Zapico, Edgar; Ordóñez-Llanos, Jordi200310.2337/diacare.26.7.2048Diabetes Care[ISSN 0149-5992],v. 26, p. 2048-20517,501Q1Artículo
Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretionWägner, Ana M. ; Ordóñez-Llanos, Jordi; Arcelus, Rosa; Bonet, Rosa; Jorba, Oscar, et al200310.1016/S0026-0495(03)00090-8Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 52, p. 1038-10422,013Q3Artículo
Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemiaWägner, Ana M. ; Jorba, Oscar; Bonet, Rosa; Ordóñez-Llanos, Jordi; Pérez, Antonio200310.1210/jc.2003-030153Journal of Clinical Endocrinology and Metabolism[ISSN 0021-972X],v. 88, p. 3212-32175,873Q1Artículo
Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetesWägner, Ana M. ; Ordóñez-Llanos, Jordi; Jorba, Oscar; Pérez, Antonio200410.1016/j.metabol.2004.07.005Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 53, p. 15162,143Q3Comentario
Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetesWägner, Ana María ; Pérez, Antonio; Sánchez-Quesada, Jose Luis; Ordóñez-Llanos, Jordi200510.2337/diacare.28.7.1798Diabetes Care[ISSN 0149-5992],v. 28, p. 1798-18007,844Q1Artículo
Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patientsRigla, Mercedes; Wägner, Ana Maria ; Borrell, Montserrat; Mateo, José; Foncuberta, Jordi, et al200610.1016/j.metabol.2005.11.010Metabolism: Clinical and Experimental[ISSN 0026-0495],v. 55, p. 1437-14422,497Q2Artículo
Electronegative low-density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic controlBenítez, Sónia; Pérez, Antonio; Sánchez-Quesada, José Luis; Wagner, Ana María ; Rigla, Mercedes, et al200710.1002/dmrr.643Diabetes/Metabolism Research and Reviews[ISSN 1520-7552],v. 23, p. 26-343,087Q2Artículo
Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over studyWägner, Ana María ; Sánchez-Quesada, Jose Luis; Benítez, Sonia; Bancells, Cristina; Ordóñez-Llanos, Jordi, et al201110.1016/j.diabres.2011.03.009Diabetes Research and Clinical Practice [ISSN 0168-8227], v. 93 (1), p. E25-E28, (Julio 2011)0,96Q12,754Q2Artículo